Table 1.

Baseline characteristics of the exposed population.

	1 µg S(N = 35)	1 µg S+CpG(N = 35)	3 µg S(N = 35)	3 µg S+CpG(N = 35)	10 µg S(N = 35)	Placebo(N = 35)
Age, years	33·0 (26·0–39·0) [18, 53]	39·0 (32·0–45·0) [20, 55]	37·0 (29·0–49·0) [18, 56]	34·0 (25·0–44·0) [19, 58]	37·0 (31·0–42·0) [19, 57]	32·0 (27·0–42·0) [19, 52]
Sex
Male	14 (40·0%)	14 (40·0%)	7 (20·0%)	15 (42·9%)	18 (51·4%)	14 (40·0%)
Female	21 (60·0%)	21 (60·0%)	28 (80·0%)	20 (57·1%)	17 (48·6%)	21 (60·0%)
Ethnicity
Asian	35 (100%)	35 (100%)	35 (100%)	35 (100%)	35 (100%)	35 (100%)
Body mass index	24·59 (20·76–27·85) [17·19, 35·06]	24·85 (21·42–26·33) [17·19, 30·06]	23·95 (21·23–27·96) [18·71, 33·73]	23·95 (21·70–25·92) [17·50, 31·79]	24·52 (21·26–27·68) [17·88, 35·06]	23·12 (21·72–27·22) [17·85, 32·78]

Data are median (q1-q3) and [min, max] or n (%).